Medicamen Biotech Limited · Q3FY22
Result on 8 Feb 2022, first traded on 9 Feb 2022; judged on 19 Sep 2026. No read was made before it — it is recorded for the base rate. The company's page →
unreadverdict
—the read
-25.8%vs market, 10 sessions
-9.4%T+1
1 · What the read said
No read. Either the company was not on the calendar in the seven days before the result, or it was excluded that week — the trail below says which.
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
Close before₹849.40the base every move below is measured from
T+1-9.4%
T+10-27.0%market -1.2%
vs market-25.8%no sector index mapped
Best close after-7.2%traded as high as -1.7% on 9 Feb
Worst close after-27.0%traded as low as -29.6% on 22 Feb
Run-up, 30 sessions-14.1%into the result
52-week range14% below high54% above low
- Delivery share
- -6.0 points in the fortnight before, against the month before that
- Volume
- 0.21× its prior month, in the fortnight before
- Habit held
- unknown — could not be checked
- Announced
- Wed, after the close — the reaction session is the next day
- Peers reporting
- 0 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- No read was made before this result; recorded for the base rate.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
0 morningsNo morning read was recorded for this result.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base |
|---|---|---|---|---|---|---|---|---|
| T-29 | 27 Dec | 999.40 | 1,019.80 | 975.60 | 988.70 | — | +16.40% | -1.05% |
| T-28 | 28 Dec | 999.90 | 1,008.95 | 904.40 | 965.85 | -2.31% | +13.71% | -0.19% |
| T-27 | 29 Dec | 985.00 | 995.00 | 940.15 | 947.25 | -1.93% | +11.52% | -0.31% |
| T-26 | 30 Dec | 965.00 | 965.00 | 906.00 | 922.05 | -2.66% | +8.55% | -0.36% |
| T-25 | 3 Jan | 898.90 | 999.00 | 887.00 | 980.10 | +6.30% | +15.39% | +2.08% |
| T-24 | 4 Jan | 986.90 | 1,005.00 | 952.50 | 983.70 | +0.37% | +15.81% | +3.12% |
| T-23 | 5 Jan | 984.70 | 1,000.00 | 947.50 | 966.65 | -1.73% | +13.80% | +3.81% |
| T-22 | 6 Jan | 951.00 | 964.00 | 930.15 | 953.05 | -1.41% | +12.20% | +2.77% |
| T-21 | 7 Jan | 964.50 | 964.50 | 935.00 | 941.60 | -1.20% | +10.85% | +3.16% |
| T-20 | 10 Jan | 949.90 | 959.00 | 910.65 | 916.75 | -2.64% | +7.93% | +4.27% |
| T-19 | 11 Jan | 929.00 | 929.00 | 869.20 | 877.20 | -4.31% | +3.27% | +4.57% |
| T-18 | 12 Jan | 887.70 | 887.70 | 844.15 | 848.85 | -3.23% | -0.06% | +5.48% |
| T-17 | 13 Jan | 841.00 | 926.95 | 827.50 | 870.80 | +2.59% | +2.52% | +5.74% |
| T-16 | 14 Jan | 882.90 | 896.05 | 861.35 | 869.80 | -0.11% | +2.40% | +5.73% |
| T-15 | 17 Jan | 850.00 | 877.00 | 846.50 | 855.95 | -1.59% | +0.77% | +6.03% |
| T-14 | 18 Jan | 861.55 | 870.00 | 832.40 | 839.35 | -1.94% | -1.18% | +4.90% |
| T-13 | 19 Jan | 840.00 | 855.20 | 827.30 | 840.15 | +0.10% | -1.09% | +3.89% |
| T-12 | 20 Jan | 855.45 | 862.05 | 831.20 | 837.70 | -0.29% | -1.38% | +2.84% |
| T-11 | 21 Jan | 832.85 | 840.00 | 808.00 | 815.95 | -2.60% | -3.94% | +2.03% |
| T-10 | 24 Jan | 805.00 | 860.00 | 767.00 | 839.90 | +2.94% | -1.12% | -0.68% |
| T-9 | 25 Jan | 813.00 | 857.10 | 813.00 | 841.25 | +0.16% | -0.96% | +0.06% |
| T-8 | 27 Jan | 849.00 | 853.50 | 824.50 | 844.75 | +0.42% | -0.55% | -0.91% |
| T-7 | 28 Jan | 850.00 | 856.85 | 809.45 | 823.80 | -2.48% | -3.01% | -0.95% |
| T-6 | 31 Jan | 835.00 | 842.60 | 802.50 | 808.00 | -1.92% | -4.87% | +0.42% |
| T-5 | 1 Feb | 820.00 | 842.90 | 810.20 | 816.85 | +1.10% | -3.83% | +1.80% |
| T-4 | 2 Feb | 834.00 | 835.00 | 812.40 | 824.30 | +0.91% | -2.96% | +2.97% |
| T-3 | 3 Feb | 832.10 | 853.15 | 825.70 | 835.90 | +1.41% | -1.59% | +1.70% |
| T-2 | 4 Feb | 839.65 | 850.00 | 819.95 | 826.85 | -1.08% | -2.65% | +1.45% |
| T-1 | 7 Feb | 830.00 | 882.00 | 830.00 | 870.40 | +5.27% | +2.47% | -0.31% |
| base | 8 Feb | 879.00 | 898.70 | 815.00 | 849.40 | -2.41% | +0.00% | +0.00% |
| T+1 | 9 Feb result | 813.55 | 835.00 | 704.95 | 788.30 | -7.19% | -7.19% | +1.14% |
| T+2 | 10 Feb | 799.95 | 819.75 | 764.05 | 769.55 | -2.38% | -9.40% | +1.96% |
| T+3 | 11 Feb | 774.95 | 774.95 | 725.00 | 738.80 | -4.00% | -13.02% | +0.63% |
| T+4 | 14 Feb | 721.00 | 738.00 | 655.60 | 684.85 | -7.30% | -19.37% | -2.46% |
| T+5 | 15 Feb | 699.00 | 715.35 | 670.00 | 703.65 | +2.75% | -17.16% | +0.50% |
| T+6 | 16 Feb | 714.20 | 732.15 | 692.20 | 706.65 | +0.43% | -16.81% | +0.32% |
| T+7 | 17 Feb | 724.90 | 724.90 | 675.00 | 684.15 | -3.18% | -19.45% | +0.22% |
| T+8 | 18 Feb | 666.00 | 706.50 | 661.35 | 669.75 | -2.10% | -21.15% | +0.06% |
| T+9 | 21 Feb | 659.70 | 684.45 | 625.50 | 641.20 | -4.26% | -24.51% | -0.35% |
| T+10 | 22 Feb | 600.65 | 637.90 | 597.95 | 628.65 | -1.96% | -25.99% | -1.01% |
| T+11 | 23 Feb | 638.00 | 664.60 | 612.20 | 620.05 | -1.37% | -27.00% | -1.18% |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.